Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Alchemab Therapeutics
Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships
Today 4:00 EDT
From
Alchemab Therapeutics
Via
Business Wire
Alchemab Appoints Young T. Kwon as Chief Executive Officer
May 26, 2022
From
Alchemab Therapeutics
Via
Business Wire
Alchemab Announces Publication of AntiBERTa, an Antibody-Specific Machine Learning Model with Multiple Applications
May 19, 2022
From
Alchemab Therapeutics
Via
Business Wire
Alchemab Selected to Access NVIDIA Cambridge-1 Supercomputer to Advance Machine Learning Enabled Antibody Discovery
March 22, 2022
From
Alchemab Therapeutics
Via
Business Wire
Alchemab Therapeutics Appoints Young T. Kwon, PhD as Chief Financial and Operating Officer
November 15, 2021
From
Alchemab Therapeutics
Via
Business Wire
Alchemab raises £60M ($82M) in Series A financing to advance novel platform for identifying disease-modifying antibody therapeutics
April 15, 2021
From
Alchemab Therapeutics
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.